Time is running out for people in the prescription drug business who want to have a say in how their products are marketed and advertised over the Internet. The Food and Drug Administration is developing a policy addressing the increasingly sticky issue of marketing prescription drugs and other medical products on the World Wide Web.
The FDA's cutoff for written comments is Dec. 16, after which the agency will begin establishing guidelines that are likely to place tighter restrictions on what may and may not be promoted on line. (FDA, 301/443-3170)